The University of Chicago Header Logo

Connection

Jonathan Chung to Receptor, Fibroblast Growth Factor, Type 2

This is a "connection" page, showing publications Jonathan Chung has written about Receptor, Fibroblast Growth Factor, Type 2.
  1. Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. Clin Cancer Res. 2020 11 15; 26(22):5974-5989.
    View in: PubMed
    Score: 0.183
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.